JPWO2023028008A5 - - Google Patents
Info
- Publication number
- JPWO2023028008A5 JPWO2023028008A5 JP2024513300A JP2024513300A JPWO2023028008A5 JP WO2023028008 A5 JPWO2023028008 A5 JP WO2023028008A5 JP 2024513300 A JP2024513300 A JP 2024513300A JP 2024513300 A JP2024513300 A JP 2024513300A JP WO2023028008 A5 JPWO2023028008 A5 JP WO2023028008A5
- Authority
- JP
- Japan
- Prior art keywords
- ttds
- group
- aib
- analog
- lysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163236090P | 2021-08-23 | 2021-08-23 | |
| US63/236,090 | 2021-08-23 | ||
| US202263332994P | 2022-04-20 | 2022-04-20 | |
| US63/332,994 | 2022-04-20 | ||
| PCT/US2022/041095 WO2023028008A2 (en) | 2021-08-23 | 2022-08-22 | Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024532403A JP2024532403A (ja) | 2024-09-05 |
| JPWO2023028008A5 true JPWO2023028008A5 (https=) | 2025-08-29 |
| JP2024532403A5 JP2024532403A5 (https=) | 2025-08-29 |
Family
ID=85322130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513300A Pending JP2024532403A (ja) | 2021-08-23 | 2022-08-22 | 腎障害または状態の治療のためのリラキシン類似体とバソプレシン類似体との組み合わせ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240400638A1 (https=) |
| EP (1) | EP4392440A4 (https=) |
| JP (1) | JP2024532403A (https=) |
| AU (1) | AU2022334113A1 (https=) |
| CA (1) | CA3229783A1 (https=) |
| MX (1) | MX2024002335A (https=) |
| WO (1) | WO2023028008A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA52994A (fr) * | 2018-01-31 | 2021-05-05 | Sanofi Sa | Peptides à chaîne b de relaxine lipidés modifiés et leur utilisation thérapeutique |
| WO2023086913A2 (en) | 2021-11-11 | 2023-05-19 | Tectonic Therapeutic, Inc. | Relaxin-2 fusion protein analogs and methods of using same |
| KR20260035823A (ko) | 2023-05-18 | 2026-03-13 | 테크토닉 오퍼레이팅 컴퍼니 인코포레이티드 | 렐락신-2 융합 단백질 유사체 및 이를 사용하는 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015528019A (ja) * | 2012-07-31 | 2015-09-24 | ノバルティス アーゲー | セレラキシンを使用する炎症の処置 |
| CN110637027B (zh) * | 2017-02-08 | 2024-08-30 | 百时美施贵宝公司 | 包含药代动力学增强子的修饰的松弛素多肽及其用途 |
| MA52994A (fr) * | 2018-01-31 | 2021-05-05 | Sanofi Sa | Peptides à chaîne b de relaxine lipidés modifiés et leur utilisation thérapeutique |
-
2022
- 2022-08-22 US US18/685,694 patent/US20240400638A1/en active Pending
- 2022-08-22 AU AU2022334113A patent/AU2022334113A1/en active Pending
- 2022-08-22 MX MX2024002335A patent/MX2024002335A/es unknown
- 2022-08-22 WO PCT/US2022/041095 patent/WO2023028008A2/en not_active Ceased
- 2022-08-22 CA CA3229783A patent/CA3229783A1/en active Pending
- 2022-08-22 EP EP22861950.8A patent/EP4392440A4/en not_active Withdrawn
- 2022-08-22 JP JP2024513300A patent/JP2024532403A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7295871B2 (ja) | 修飾された脂質化リラキシンｂ鎖ペプチドおよびその治療的使用 | |
| US5932548A (en) | Lysine containing peptides for treatment of heart disease | |
| JP2003192698A (ja) | 糖尿病治療に有用なｇｌｐ−１アナログ | |
| US8809260B2 (en) | β-arrestin effectors and compositions and methods of use thereof | |
| JP2021512099A5 (https=) | ||
| JP2002530430A (ja) | Ｃ型肝炎ウイルスｎｓ３プロテアーゼ阻害用の医薬組成物 | |
| JP2002516872A5 (https=) | ||
| US20240400638A1 (en) | Combination of relaxin and vasopressin analogues for treatment of renal disorders or conditions | |
| EP0504168A1 (en) | Synthetic calcitonin peptides | |
| RU2016110153A (ru) | Новые пептиды и их аналоги для применения при лечении мукозита полости рта | |
| WO2001072770A1 (en) | Insulin potentiating peptides | |
| CN104853749A (zh) | 血管紧张素的口服制剂 | |
| JPWO2023028008A5 (https=) | ||
| JPWO2019149782A5 (https=) | ||
| EP0151166A1 (en) | Novel peptide hormones with calcitonin-like activity | |
| CN1255426C (zh) | 用于治疗勃起功能障碍的肽 | |
| ES2291372T3 (es) | Agonistas y antagonistas de urotensina-ii. | |
| CA2227980A1 (en) | Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone | |
| Kutina et al. | Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats | |
| JP3588472B2 (ja) | 急性膵炎治療用ブラジキニン拮抗剤 | |
| US20210171604A1 (en) | Peptides for the treatment of type 2 diabetes | |
| CN118510796A (zh) | 用于治疗肾脏病症或疾患的松弛素和加压素类似物的组合 | |
| US10570174B2 (en) | Peptides for the treatment of malignant proliferative diseases | |
| WO2026068492A1 (en) | Compounds comprising modified w peptide | |
| AU2001243942A1 (en) | Insulin potentiating peptides |